3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Respiratory Distress Syndrome
1
Prostatic Neoplasms
1
Pneumonia, Viral
1
Oligodendroglioma
1
Melanoma
1
Hodgkin Disease
1
High-Grade Anal Intraepithelial Neoplasia
1
Hematologic Neoplasms
1
HIV Infections
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Cytokine Release Syndrome
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Astrocytoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
20
Vincristine
17
Zidovudine
13
Cyclophosphamide
12
Bleomycin
12
Etoposide
10
Rituximab
6
Prednisone
6
Interferon alpha-2
6
Cytarabine
6
Liposomes
5
Filgrastim
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Specimen Handling
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Fluorouracil
4
Biopsy
4
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
interferon alfa-n1
2
fludarabine phosphate
2
fludarabine
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HIV Infections
×
Lopinavir
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled